TITLE

Prognostic significance of microsatellite instabilily determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer

AUTHOR(S)
Parc, Y.; Gueroult, S.; Mourra, N.; Serfaty, L.; Fléjou, J-F.; Tiret, E.; Parc, R.
PUB. DATE
March 2004
SOURCE
Gut;Mar2004, Vol. 53 Issue 3, p371
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Microsatellite instability (MSI) has been identified as a factor with good prognosis and chemosensitivity in stage III C colon cancer. The purpose of this study was to evaluate the routine use of immunohistochemical analysis (immunohistochemical staining of MSH2 and MLH1) to identify T3N0M0 (stage II) colon cancer with MSI and assess the prognostic value of this analysis. The study was conducted in a large cohort of patients in a single institution who had a curatively resected T3N0M0 colon cancer and were not receiving adjuvant therapy. Methods: Between June 1995 and December 2001, 142 patients (77 females) with a mean age of 68 years, suffering from T3N0M0 colon cancer curatively resected and not receiving adjuvant therapy, were checked in terms of their follow up status. The results of colonoscopy, hepatic ultrasonography, chest x ray, and blood carcinoembryological antigen were noted. All tumours were immunohistochemically stained for MSH2 and MLH1. Perineural invasion, lymphovascular invasion, and the presence of vascular neoplastic emboli were assessed. Results: Twenty four patients (17%) had MSI tumours. Patients with MSI and microsatellite stable (MSS) tumours did not differ in terms of age, perineural or lymphovascular invasion, or the presence of vascular neoplastic emboli. Patients with MSI tumours were more frequently female (18/24 v 60/118; p=0.001) and more frequently suffered from right sided cancer (19/24 v 58/118; p<0.001). Patients with MSI tumours exhibited significantly better recurrence free survival than those with MSS tumours (p = 0.02). Cox analysis identified age and MSI determined by immunohistochemistry as independent predictive factors of good prognosis (p=0.009, odds ratio 1.04 (1.01-1.08); p =0.04, odds ratio 7.9 (1.05-59.6)). Conclusions: MSI determined by immunohistochemistry is an independent predictive factor of good prognosis in T3N0M0 colon cancer. The prognosis for MSI T3N0M0 colon cancer is excellent and chemotherapy should not be proposed in these patients as immunohistochemical analysis produces rapid results.
ACCESSION #
13492614

 

Related Articles

  • Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer. Seppälä, T T; Böhm, J P; Friman, M; Lahtinen, L; Väyrynen, V M J; Liipo, T K E; Ristimäki, A P; Kairaluoma, M V J; Kellokumpu, I H; Kuopio, T H I; Mecklin, J-P // British Journal of Cancer;6/9/2015, Vol. 112 Issue 12, p1966 

    Background:The objective of the study was to examine the role of microsatellite instability (MSI) and BRAFV600Emutation in colorectal cancer (CRC) by categorising patients into more detailed subtypes based on tumour characteristics.Methods:Tumour samples from 762 population-based patients with...

  • Identification of HNPCC by molecular analysis of colorectal and endometrial tumors. Vasen, H. F. A.; Hendriks, Y.; de Jong, A. E.; van Puijenbroek, M.; Tops, C.; Bröcker-Vriends, A. H. J. T.; Wijnen, J. Th.; Morreau, H. // Disease Markers;2004, Vol. 20 Issue 4/5, p207 

    Hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) is a dominantly inherited syndrome characterized by the development of colorectal cancer, endometrial cancer and other cancers and the presence of microsatellite instability (MSI) in tumors. The Bethesda guidelines have been...

  • MSI-testing in hereditary non-polyposis colorectal carcinoma (HNPCC). Annegret Müller; Tina Bocker Edmonston; Wolfgang Dietmaier; Reinhard Büttner; Richard Fishel; Josef Rüschoff // Disease Markers;2004, Vol. 20 Issue 4/5, p225 

    Genomic instability at simple repeated sequences, termed microsatellite instability (MSI), plays an important role in the analysis of sporadic and hereditary colon cancers. In hereditary non-polyposis colorectal cancer syndrome (HNPCC) more than 90% of cases show MSI, whereas only 10–15%...

  • APC mutation and tumour budding in colorectal cancer. Jass, J.R.; Barker, M.; Fraser, L.; Walsh, M.D.; Whitehall, V.L.J.; Gabrielli, B.; Young, J.; Leggett, B.A. // Journal of Clinical Pathology;Jan2003, Vol. 56 Issue 1, p69 

    Determines the frequency of tumor budding and somatic APC mutation in a series of colorectal cancers stratified according to DNA microsatellite instability status. Morphological features seen at the invasive front of the primary tumor that are associated with prognosis in colorectal cancer;...

  • Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance. Popat, Sanjay; Wort, Richard; Houlston, Richard S // BMC Cancer;2006, Vol. 6, p150 

    Background: Studies indicate that thymidylate synthase (TS) expression, p53 and mismatch repair status have potential to influence colorectal cancer (CRC) outcome. There is, however, little data on the inter-relationship between these three markers. We sought to investigate whether relationships...

  • SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancers. Chia, June A.; Simms, Lisa A.; Cozzi, Sarah-Jane; Young, Joanne; Jass, Jeremy R.; Walsh, Michael D.; Spring, Kevin J.; Leggett, Barbara A.; Whitehall, Vicki L. J. // BMC Cancer;2006, Vol. 6, p1 

    Background: SnoN is an important regulator of the transforming growth factor beta (TGFÎ’) signalling pathway and has been shown to exhibit both tumour promotion and suppression activity. Methods: To further explore the role of this complex molecule in colorectal tumorigenesis, we examined 52...

  • MicroRNA dysregulation as a prognostic biomarker in colorectal cancer. Dong, Yujuan; Yu, Jun; Simon, SM Ng // Cancer Management & Research;2014, Vol. 6, p405 

    Colorectal cancer (CRC) is one of the most potentially curable cancers, yet it remains the fourth most common overall cause of cancer death worldwide. The identification of robust molecular prognostic biomarkers can refine the conventional tumor-node-metastasis staging system, avoid understaging...

  • Predominance of CIN versus MSI in the development of rectal cancer at young age. Fernebro, Eva; Halvarsson, Britta; Baldetorp, Bo; Nilbert, Mef // BMC Cancer;2002, Vol. 2, p25 

    Background: Development of proximal and distal colorectal cancers involve partly different mechanisms associated with the microsatellite instability (MSI) and the chromosomal instability (CIN) pathways. Colorectal cancers in patients under 50 years of age represent about 5% of the total number...

  • Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer. Wallin, U.; Glimelius, B.; Jirström, K.; Darmanis, S.; Nong, R. Y.; Pontén, F.; Johansson, C.; Påhlman, L.; Birgisson, H. // British Journal of Cancer;5/10/2011, Vol. 104 Issue 10, p1619 

    Background:Growth differentiation factor 15 (GDF15) belongs to the transforming growth factor beta superfamily and has been associated with activation of the p53 pathway in human cancer. The aim of this study was to assess the prognostic value of GDF15 in patients with colorectal cancer...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics